Prestige Brand Holdings Inc (PBH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Prestige Brand Holdings Inc stock (PBH) is currently trading at $62.00. Prestige Brand Holdings Inc PE ratio is 16.09. Prestige Brand Holdings Inc PS ratio (Price-to-Sales) is 2.66. Analyst consensus price target for PBH is $77.83. WallStSmart rates PBH as Hold.
- PBH PE ratio analysis and historical PE chart
- PBH PS ratio (Price-to-Sales) history and trend
- PBH intrinsic value — DCF, Graham Number, EPV models
- PBH stock price prediction 2025 2026 2027 2028 2029 2030
- PBH fair value vs current price
- PBH insider transactions and insider buying
- Is PBH undervalued or overvalued?
- Prestige Brand Holdings Inc financial analysis — revenue, earnings, cash flow
- PBH Piotroski F-Score and Altman Z-Score
- PBH analyst price target and Smart Rating
Prestige Brand Holdings Inc
📊 No data available
Try selecting a different time range
PBH Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Prestige Brand Holdings Inc (PBH)
PBH trades 156% above its Graham fair value of $25.77, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Prestige Brand Holdings Inc (PBH) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in operating margin, price/book, profit margin. Concerns around revenue growth and eps growth. Fundamentals are solid but monitor weak areas for improvement.
Prestige Brand Holdings Inc (PBH) Key Strengths (5)
111.42% of shares held by major funds and institutions
Strong operational efficiency: $29 kept per $100 revenue
Trading at 1.58x book value, attractively priced
Strong profitability: $17 kept per $100 revenue
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Prestige Brand Holdings Inc (PBH) Areas to Watch (5)
Revenue declining -2.40%, a shrinking business
Earnings declining -20.50%, profits shrinking
Moderate profitability with room for improvement
Growth is fairly priced, not cheap, not expensive
Revenue is fairly priced at 2.66x sales
Prestige Brand Holdings Inc (PBH) Detailed Analysis Report
Overall Assessment
This company scores 57/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.2/10) while 5 fall into concern territory (avg 3.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Operating Margin, Price/Book. Valuation metrics including Price/Book (1.58) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 29.10%, Profit Margin at 16.90%.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Return on Equity. Some valuation metrics including PEG Ratio (1.97), Price/Sales (2.66) suggest expensive pricing. Growth concerns include Revenue Growth at -2.40%, EPS Growth at -20.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 10.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 10.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -2.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Operating Margin) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PBH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PBH's Price-to-Sales ratio of 2.66x trades at a 26% premium to its historical average of 2.11x (74th percentile). The current valuation is 26% below its historical high of 3.59x set in Nov 2015, and 245% above its historical low of 0.77x in Mar 2009. Over the past 12 months, the PS ratio has compressed from ~3.0x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Prestige Brand Holdings Inc (PBH) · HEALTHCARE › DRUG MANUFACTURERS - SPECIALTY & GENERIC
The Big Picture
Prestige Brand Holdings Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 1.1B with 240% decline year-over-year. Profit margins of 16.9% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 1030.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 75M in free cash flow and 78M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 240% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Sector dynamics: monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive moves, and regulatory changes that could impact Prestige Brand Holdings Inc.
Bottom Line
Prestige Brand Holdings Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Prestige Brand Holdings Inc(PBH)
NYSE
HEALTHCARE
DRUG MANUFACTURERS - SPECIALTY...
USA
Prestige Consumer Healthcare Inc., develops, manufactures, markets, distributes and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company is headquartered in Tarrytown, New York.